Identification and synthesis of (Z)-3'-hydroxy clomiphene as a new potential doping-relevant metabolite of clomiphene.
Autor: | Euler L; Institute of Biochemistry/Center for Preventive Doping Research, German Sport University Cologne, Cologne, Germany., Mürdter T; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany., Heinkele G; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany., Schwab M; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; Departments of Clinical Pharmacology and of Biochemistry and Pharmacy, University of Tübingen, Tübingen, Germany., Miller GD; Sports Medicine and Research Testing Laboratory, South Jordan, Utah, USA., Eichner D; Sports Medicine and Research Testing Laboratory, South Jordan, Utah, USA., Thomas A; Institute of Biochemistry/Center for Preventive Doping Research, German Sport University Cologne, Cologne, Germany., Thevis M; Institute of Biochemistry/Center for Preventive Doping Research, German Sport University Cologne, Cologne, Germany.; European Monitoring Center for Emerging Doping Agents (EuMoCEDA), Cologne/Bonn, Germany. |
---|---|
Jazyk: | angličtina |
Zdroj: | Rapid communications in mass spectrometry : RCM [Rapid Commun Mass Spectrom] 2023 Sep 15; Vol. 37 (17), pp. e9599. |
DOI: | 10.1002/rcm.9599 |
Abstrakt: | A recent study addressed the possibility of unintentional ingestion of clomiphene through residues in chicken eggs. The method developed here helped distinguish between microdose intake of (E/Z)-clomiphene citrate and consumption of clomiphene-containing eggs by the urinary pattern of four mono-hydroxylated clomiphene metabolites. However, reanalyses of doping-control samples, which showed an adverse analytical finding for clomiphene, revealed a hydroxy clomiphene (HC) isomer that was not found after microdose intake or after consumption of clomiphene-containing eggs and could not be assigned to any of the available reference compounds. The aim of the present follow-up study was to identify this HC isomer and to characterize this metabolite with respect to its potential properties as long-term metabolite in doping controls. Methods: (E/Z)-3'-HC and (E/Z)-4'-HC were synthesized involving the McMurry reaction. An ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was developed and optimized after a derivatization step with dansyl chloride to separate eight HC isomers. Using this method, urine samples from a controlled clomiphene administration study were analyzed, in which male study participants received therapeutic doses of clomiphene for 30 days and collected urine samples for up to 8 months. Thus, isomer-specific HC elimination profiles could be monitored. Results: The metabolite previously found in doping-control samples was identified as (Z)-3'-HC. The elimination profiles of the different HCs confirmed previous results, with (Z)-3-HC being the most abundant urinary hydroxy metabolite shortly after administration. A new finding was that the data suggest that (Z)-3'-HC is excreted at higher relative concentrations only several weeks after drug intake. Conclusion: These findings might be of particular importance in sport drug testing as they can assist in the decision-making process to distinguish between intentional doping and inadvertent exposure to clomiphene via food contamination. (© 2023 The Authors. Rapid Communications in Mass Spectrometry published by John Wiley & Sons Ltd.) |
Databáze: | MEDLINE |
Externí odkaz: |